Your browser doesn't support javascript.
loading
The neuronal calcium ion channel activity of constrained analogues of MONIRO-1.
Cardoso, Fernanda C; Marliac, Marie-Adeline; Geoffroy, Chloe; Schmit, Matthieu; Bispat, Anjie; Lewis, Richard J; Tuck, Kellie L; Duggan, Peter J.
Afiliação
  • Cardoso FC; Institute for Molecular Bioscience, The University of Queensland, St Lucia, QLD 4072, Australia.
  • Marliac MA; CSIRO Manufacturing, Bag 10, Clayton South, Victoria 3169, Australia; Institut de Recherche de Chimie Paris, CNRS - Chimie Paris Tech, 11 rue Pierre et Marie Curie, Paris 75005, France.
  • Geoffroy C; CSIRO Manufacturing, Bag 10, Clayton South, Victoria 3169, Australia; Institut de Recherche de Chimie Paris, CNRS - Chimie Paris Tech, 11 rue Pierre et Marie Curie, Paris 75005, France.
  • Schmit M; CSIRO Manufacturing, Bag 10, Clayton South, Victoria 3169, Australia; School of Chemistry, Monash University, Victoria 3800, Australia.
  • Bispat A; CSIRO Manufacturing, Bag 10, Clayton South, Victoria 3169, Australia; School of Chemistry, Monash University, Victoria 3800, Australia.
  • Lewis RJ; Institute for Molecular Bioscience, The University of Queensland, St Lucia, QLD 4072, Australia.
  • Tuck KL; School of Chemistry, Monash University, Victoria 3800, Australia. Electronic address: kellie.tuck@monash.edu.
  • Duggan PJ; CSIRO Manufacturing, Bag 10, Clayton South, Victoria 3169, Australia; College of Science and Engineering, Flinders University, GPO Box 2100, Adelaide, South Australia, Australia. Electronic address: peter.duggan@csiro.au.
Bioorg Med Chem ; 28(18): 115655, 2020 09 15.
Article em En | MEDLINE | ID: mdl-32828422
ABSTRACT
Structural modifications of the neuronal calcium channel blocker MONIRO-1, including constraining the phenoxyaniline portion of the molecule and replacing the guanidinium functionality with tertiary amines, led to compounds with significantly improved affinities for the endogenously expressed CaV2.2 channel in the SH-SY5Y neuroblastoma cell line. These analogues also showed promising activity towards the CaV3.2 channel, recombinantly expressed in HEK293T cells. Both of these ion channels have received attention as likely targets for the treatment of neuropathic pain. The dibenzoazepine and dihydrobenzodiazepine derivatives prepared in this study show an encouraging combination of neuronal calcium ion channel inhibitory potency, plasma stability and potential to cross the blood-brain-barrier.
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Benzodiazepinas / Proteínas Recombinantes / Bloqueadores dos Canais de Cálcio / Canais de Cálcio / Anilidas / Neuralgia / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Bioorg Med Chem Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Benzodiazepinas / Proteínas Recombinantes / Bloqueadores dos Canais de Cálcio / Canais de Cálcio / Anilidas / Neuralgia / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Bioorg Med Chem Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália